Total Payments
$8,501
2024 Payments
$2,583
Companies
44
Transactions
505
Medicare Patients
2,539
Medicare Billing
$253,627
Payment Breakdown by Category
Food & Beverage$7,889 (92.8%)
Other$493.18 (5.8%)
Education$118.74 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,889 | 498 | 92.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $400.00 | 1 | 4.7% |
| Education | $118.74 | 5 | 1.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $93.18 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,610 | 129 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,414 | 82 | $0 (2024) |
| QOL Medical, LLC | $625.08 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $520.49 | 37 | $0 (2024) |
| Janssen Biotech, Inc. | $508.12 | 33 | $0 (2024) |
| Daiichi Sankyo Inc. | $347.38 | 18 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $298.04 | 12 | $0 (2024) |
| GENZYME CORPORATION | $249.50 | 12 | $0 (2024) |
| Celgene Corporation | $244.35 | 13 | $0 (2024) |
| Gilead Sciences, Inc. | $242.04 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,583 | 138 | ABBVIE INC. ($548.59) |
| 2023 | $1,987 | 123 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($460.62) |
| 2022 | $958.82 | 58 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($245.95) |
| 2021 | $731.14 | 49 | AbbVie Inc. ($245.94) |
| 2020 | $687.10 | 20 | QOL Medical, LLC ($409.66) |
| 2019 | $531.92 | 40 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($150.56) |
| 2018 | $664.72 | 52 | AbbVie, Inc. ($162.89) |
| 2017 | $357.68 | 25 | Valeant Pharmaceuticals North America LLC ($122.74) |
All Payment Transactions
505 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $39.85 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $2.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: INFLIXIMAB | ||||||
| 12/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Immunology | ||||||
| 11/10/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: LIVER DISEASE | ||||||
| 11/05/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: HEMATOLOGY | ||||||
| 10/29/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.31 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 744 | 13,605 | $347,067 | $82,512 |
| 2022 | 14 | 613 | 711 | $252,421 | $58,214 |
| 2021 | 16 | 651 | 788 | $250,759 | $62,338 |
| 2020 | 12 | 531 | 619 | $201,147 | $50,562 |
Total Patients
2,539
Total Services
15,723
Medicare Billing
$253,627
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 161 | 213 | $42,813 | $18,221 | 42.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 135 | 137 | $91,379 | $16,951 | 18.6% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 15 | 12,750 | $25,500 | $11,232 | 44.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 47 | 47 | $37,224 | $9,564 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $18,290 | $5,988 | 32.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 53 | 55 | $24,585 | $4,339 | 17.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 23 | 23 | $12,765 | $3,888 | 30.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 99 | 106 | $60,632 | $3,440 | 5.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 57 | $8,265 | $3,025 | 36.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 17 | 17 | $8,245 | $1,762 | 21.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 26 | $3,796 | $1,586 | 41.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 23 | 30 | $8,520 | $1,381 | 16.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,228 | $1,103 | 34.2% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 29 | 73 | $1,825 | $32.94 | 1.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 100 | 101 | $67,367 | $12,596 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 103 | $20,703 | $8,972 | 43.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 36 | 38 | $30,096 | $7,218 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $18,600 | $6,437 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 100 | $14,500 | $5,824 | 40.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 79 | 85 | $48,620 | $3,868 | 8.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 32 | 37 | $16,539 | $3,313 | 20.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 15 | 15 | $8,325 | $2,662 | 32.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 25 | $6,725 | $2,476 | 36.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 39 | $5,694 | $2,009 | 35.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $6,105 | $1,218 | 19.9% |
About Dr. Scott Leverage, MD
Dr. Scott Leverage, MD is a Gastroenterology healthcare provider based in Crestview Hills, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1700064995.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Leverage, MD has received a total of $8,501 in payments from pharmaceutical and medical device companies, with $2,583 received in 2024. These payments were reported across 505 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($7,889).
As a Medicare-enrolled provider, Leverage has provided services to 2,539 Medicare beneficiaries, totaling 15,723 services with total Medicare billing of $253,627. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Crestview Hills, KY
- Active Since 02/10/2008
- Last Updated 11/14/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1700064995
Products in Payments
- XIFAXAN (Drug) $1,138
- DUPIXENT (Biological) $547.54
- Sucraid (Drug) $492.28
- RINVOQ (Biological) $351.74
- INJECTAFER (Drug) $336.87
- ZEPOSIA (Drug) $244.35
- STELARA (Biological) $239.20
- VIBERZI (Drug) $228.83
- LINZESS (Drug) $226.54
- IBSRELA (Drug) $216.08
- ENTYVIO (Biological) $212.97
- Humira (Biological) $209.63
- HUMIRA (Biological) $202.45
- GATTEX (Drug) $186.11
- XELJANZ (Drug) $168.61
- OMVOH (Drug) $152.20
- MAVYRET (Drug) $147.87
- TREMFYA (Drug) $139.86
- TRULANCE (Drug) $137.81
- SUCRAID (Drug) $132.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Crestview Hills
Dr. Zahid Saeed, M.d, M.D
Gastroenterology — Payments: $723,616
Gastroenterology $723,616
Chadwick Hatfield, M.d, M.D
Gastroenterology — Payments: $11,845
Gastroenterology $11,845
Dr. Karlina Patton, M.d, M.D
Gastroenterology — Payments: $9,693
Gastroenterology $9,693
Dr. Daniel Fagel, M.d, M.D
Gastroenterology — Payments: $9,301
Gastroenterology $9,301
Dr. Suma Chennubhotla, M.d, M.D
Gastroenterology — Payments: $4,828
Gastroenterology $4,828
Dr. Suzana Brozovic, M.d, M.D
Gastroenterology — Payments: $2,427
Gastroenterology $2,427